NCT06295809 2026-03-27
INTerpath-007
Merck Sharp & Dohme LLC
Phase 2/3 Completed
Clinical Trials
13 trialsNCT01005745 2025-12-19
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed
NCT00975520 2024-11-27
RTN2
Melanoma and Skin Cancer Trials Limited
Phase NA Completed
NCT05253144 2024-05-08
Rational-MCC
University of Birmingham
Phase NA Completed
NCT05853315 2023-05-16
BCC Excision Revisited
Medical University of Vienna
Completed
NCT01720407 2022-12-06
ImiReduc
Nantes University Hospital
Phase 3 Completed
NCT02623101 2019-09-20
Reflectance Confocal Microscopy in Basal Cell Carcinoma
Radboud University Medical Center
Phase NA Completed
NCT00126555 2019-08-30
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01760499 2017-04-19
Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02285790 2016-04-13
B-OSS
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT00004022 2013-04-05
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00002860 2012-01-13
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
SWOG Cancer Research Network
Phase 2 Completed